|
This article is being developed. You can contribute or discuss its development.If it is ready to be checked, you can submit it for review?Template:Assistant:Submit/formSubmit for review.This is not a way to ask others to expand or finish the article!If original reporting is contained in this article, you must provide notes. |
| This article is being developed. You can contribute or discuss its development.If it is ready to be checked, you can submit it for review?Template:Assistant:Submit/formSubmit for review.This is not a way to ask others to expand or finish the article!If original reporting is contained in this article, you must provide notes. |
Friday, April 1, 2022
A revolution is taking place for victims of Type One diabetes. Nearly 900 people in the United Kingdom with Type One diabetes are being given a trial of an artificial pancreas. This works by having a sensor injected under the skin, which sends wireless messages to a pump that gives amounts of insulin according to how much the patient needs. Nearly 400, 000 people in the United Kingdom have Type One diabetes. A century after the first diabetes patient was administered insulin, more than 35 National Health Service diabetes centres in England are testing the revolutionary hybrid loop system – also known as an artificial pancreas.